In 1965, Phil Gold and Samuel Freedman co-discovered the carcinoembryonic antigen (CEA), which is produced during the growth of cancer in digestive cells, in particular in the large intestine, and now serves as the basis of a blood test used to identify cancer. Innumerable human lives have been saved thanks to the test.
Both men pursued have illustrious medical careers for several subsequent decades.
In 1978, Dr. Gold became the first Director of the McGill Cancer Centre. In 1980, he was named The Montreal General Hospital’s Physician-in-Chief and served as the Chairman of the Department of Medicine at McGill University between 1985 and 1990. In 1995 he became the Executive Director of the Clinical Research Centre of the Research Institute of the McGill University Health Centre.
Dr. Freedman was the Dean of McGill’s Faculty of Medicine from 1977 to 1981, and McGill’s Vice Principal for Academic Affairs from 1981 to 1991. From 1991 to 2000, he was the Director of the Lady Davis Research Institute at the Jewish General Hospital. Dr. Freedman was named a Professor Emeritus at McGill in 2000.